Pure Global AI
PMDA 医薬機審発0331第4号

医薬機審発0331第4号 (31 March 2026)

Medical-device approval application instructions — 31 March 2026 amendment and reference text
JapanPharmaceuticals and Medical Devices AgencyRegistrationCurrentness under review
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

What this code is

医薬機審発0331第4号 (31 March 2026) is the official PMDA identifier for “Medical-device approval application instructions — 31 March 2026 amendment and reference text”. 医薬機審発0331第4号 (31 March 2026) is the official identifier PMDA uses for this instrument.

Instrument
医薬機審発0331第4号
Full name
医薬機審発0331第4号 (31 March 2026)
Category
Registration
Source links
Source publication
Japanese
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

About this regulation

Medical-device approval application instructions — 31 March 2026 amendment and reference text

The full19-page MHLW notice includes the amended/prior comparison and reference instructions. It expressly applies to medical-device approval applications from1May2026. Comparison columns must retain their separate meanings; this is not a universal brand or factory-change rule. Held bytes are preserved in full; this is not a current-law or whole-country completeness certification. The two-column/four-column comparative material is a source comparison, not a licence to combine prior and revised provisions.

医薬機審発0331第4号 (31 March 2026) is the official identifier PMDA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.